Inhibitor Therapeutics Inc (INTI:OTCMKTS)

$0.09 0.00 (0.00%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 83

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Inhibitor Therapeutics Inc (INTI:OTCMKTS) News Sources

HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Inhibitor Program at 15th European Lupus Meeting

Yahoo Finance UK

external link

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Markets Insider

external link

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics

Yahoo Finance

external link

Oruka Therapeutics: A Potential Future Psoriasis Play

Seeking Alpha

external link

Melodia Therapeutics Announces U.S. Patent Grant Covering MLD-151

Yahoo Finance

external link

Alterome Therapeutics to Participate in Upcoming Investor Conferences

Le Lézard

external link

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Yahoo Finance UK

external link

Cadrenal Therapeutics Inc.: Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement

FinanzNachrichten.de

external link

Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

Markets Insider

external link

Advancing a Mutant-Selective PI3Kα Inhibitor for the Treatment of HR+/HER2- Advanced Breast Cancer

European Medical Journal

external link
INTI stock
INTI stock price
INTI stock price today
INTI stock prediction
INTI earnings date
INTI news
INTI price
INTI share
INTI share price
INTI shares
INTI ceo
INTI premarket
$INTI
INTI ticker
INTI after hours
INTI stock
INTI stock price
INTI stock price today
INTI stock prediction
INTI earnings date
INTI news
INTI price
INTI share
INTI share price
INTI shares
INTI ceo
INTI premarket
$INTI
INTI ticker
INTI after hours

Inhibitor Therapeutics Inc (INTI:OTCMKTS) FAQs

toggle

What is the current price of Inhibitor Therapeutics Inc (INTI:OTCMKTS)?

The current price of Inhibitor Therapeutics Inc (INTI:OTCMKTS) is $0.09.


toggle

Inhibitor Therapeutics Inc (INTI:OTCMKTS) absolute price change since previous trading day?

The absolute price change of Inhibitor Therapeutics Inc (INTI:OTCMKTS) since the previous trading day is $0.00.


toggle

Inhibitor Therapeutics Inc (INTI:OTCMKTS) percentage price change since previous trading day?

The percentage price change of Inhibitor Therapeutics Inc (INTI:OTCMKTS) since the previous trading day is 0.00%.


toggle

What is This Week's average sentiment score for Inhibitor Therapeutics Inc (INTI:OTCMKTS)?

This Week's average sentiment score for Inhibitor Therapeutics Inc (INTI:OTCMKTS) is 83 out of 100.


toggle

What is This Week's average sentiment for Inhibitor Therapeutics Inc (INTI:OTCMKTS)?

This Week's sentiment for Inhibitor Therapeutics Inc (INTI:OTCMKTS) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.